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ABSTRACT 
 MK-STYX [MAPK (mitogen-activated protein kinase) phosphoserine/threonine/
tyrosine binding protein] is a pseudophosphatase of the MAPK phosphatase family. 
Though structurally related to the MAPK dual specificity phosphatases, MK-STYX lacks 
both the critical nucleophilic cysteine and adjacent histidine residues in the active site 
signature motif (HCX5R) required for catalysis. Thus, MK-STYX is catalytically 
inactive. Despite its lack of catalytic activity, MK-STYX maintains its ability to bind 
phosphorylated proteins but not dephosphorylate them. This thesis focuses on the role of 
MK-STYX in neuronal differentiation signal transduction cascades. The rat 
pheochromocytoma (PC12) cell line was used as a model system to study neuronal 
differentiation. Prior studies have shown that stimulation by neurotrophin nerve growth 
factor initiates sustained activation of a Ras-dependent MAPK phosphorylation cascade. 
Specifically, it is the sustained activation of extracellular signal-regulated kinase (ERK) 
1/2 that leads to neuronal differentiation in PC12 cells. The results presented here 
confirm that MK-STYX causes neuronal differentiation in PC12 cells, suggesting a role 
in modulation of the MAPK pathway. Initially, MK-STYX modulation of the small G-
protein Ras was investigated, because activation of Ras is known to lead to activation of 
the MAPK signal transduction cascade. This thesis shows that MK-STYX causes a very 
transient decrease in the activation of Ras. To further investigate the role of MK-STYX in 
the MAPK cascade, the kinase activity of MEK was inhibited.Without MEK activation of 
ERK 1/2, PC12 cells should not be able to differentiate. However, despite the presence of 
an inhibitor, MK-STYX continued to induce neuronal differentiation, suggesting MK-
STYX acts independently of the MAPK pathway. This finding led to investigation of the 
small G-protein, RhoA. RhoA is involved in actin cytoskeleton remodeling. Prior studies 
have shown that activation of RhoA inhibits the initiation of neuronal outgrowths, 
whereas inactivation of RhoA promotes it. These studies provide evidence that MK-
STYX decreases activation RhoA leading to the induction of neurite outgrowth. In 
summary, this thesis demonstrates that MK-STYX can induce PC12 neuronal 
differentiation through inactivation of RhoA and independently of the MAPK pathway. 
This strongly supports a model in which the pseudophosphatase MK-STYX has a critical 
role as a regulator in PC12 neuronal differentiation.
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INTRODUCTION
Phosphorylation Signaling Cascades
 Signal transduction cascades are critical for controlling and coordinating cellular 
responses. Protein phosphorylation is an important post-translational modification of 
these transduction cascades. Phosphorylation modifications induce reversible protein 
conformational changes to regulate protein activity. In mammalian cells, the hydroxyl 
group of threonine, serine, or tyrosine amino acid residues can be reversibly 
phosphorylated by kinases and phosphatases to control protein-protein interactions.  
Kinases catalyze the transfer of a phosphoryl group (PO32-) from adenosine triphosphate 
(ATP) to the hydroxyl group of the target protein, whereas phosphatases catalyze the 
removal of the phosphoryl group and regeneration of the hydroxyl group (Roskoski, 
2012). Protein phosphorylation and de-phosphorylation allow kinases to control the 
amplitude of a signal response and phosphatases to control the rate and duration of a 
response (Hornberg et al., 2005). This control of cellular signal responses is critical to the 
regulation of neuronal development. Pseudoenzymes such as pseudophosphatases and 
pseudokinases add another layer of complexity to the control of theses signal transduction 
cascades. These pseudoenzymes are catalytically inactive but maintain the ability to bind 
target substrates. Therefore, it is critical to understand the role these pseudoenzymes play 
in the regulation of signal transduction cascades. This thesis focuses on the role of 
pseudophosphatase MK-STYX in neuronal differentiation signal transduction cascades.
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The Rat Pheochromocytoma (PC12) cell line
 The rat pheochromocytoma (PC12) cell line is a model system for the study of 
neuronal signal transduction. PC12 cells respond reversibly to simulation by extracellular 
neurotrophins such as nerve growth factor (NGF) causing a cessation of cellular 
proliferation and induction of neuronal differentiation into sympathetic-like neurons 
(Fujita et al., 1989).  Unlike sympathetic neurons, PC12 cells do not require NGF for 
survival (Green and Tischler, 1976). NGF mediates a cellular response through binding 
receptor tyrosine kinases (RTKs). RTKs are transmembrane receptors. A subfamily of the 
RTKs are the neurotrophic tyrosine kinase (Trk) receptors; TrkA, TrkB, and TrkC 
(Kaplan and Stephens, 1994;Choura and Rebaï, 2011;Basson, 2012). TrkA has a high 
ligand affinity for NGF (Weismann and de Vos, 2001;Talebian et al., 2013).  Upon ligand 
binding, TrkA homodimerizes and trans-autophosphorylates the tyrosine residues of its 
cytoplasmic domain allowing proteins to bind the phospho-tyrosine residues leading to 
the recruitment of adaptor proteins with Src homology 2 (SH2) domains to activate 
intracellular signaling pathways (Kaplan and Stephens 1994; Cheung and Ip, 2008; Lim 
and Pawson, 2010). The activity of kinases initiates the phosphorylation cascade of the 
signaling pathway.  
Kinases in Neuronal Development
 The most well-characterized neuronal signal transduction pathways are the 
mitogen activated protein kinase (MAPK) cascade, phosphatidylinositol 3-kinase (PI3K) 
cascade, and the phospholipase C cascade (Hausott et al., 2009). The MAPK and PI3K 
cascades are strongly associated with the regulation of neuronal development, whereas 
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the phospholipase C pathway is mainly involved in neurotrophin release (Canossa et al., 
1997; Hausott et al., 2009). It is well characterized that sustained activation of the MAPK 
cascade induces neuronal differentiation in PC12 cells. 
Mitogen Activated Protein Kinase Signaling 
 The mechanism of MAPK signal transduction is a three-tier phosphorylation 
cascade of MAPK kinase kinase, MAPK kinase, and MAPK (Figure 1). GTPase Ras 
activates the three-tiered MAPK cascade. As a GTPase, Ras cycles between an inactive 
GDP bound form and an active GTP bound form (Wennerberg et al., 2005). These 
conversions are tightly regulated by guanine nucleotide exchange factors (GEFs) and 
GTPase activating proteins (GAPs). GEFs increase the GDP/GTP exchange rate and 
GAPs stimulate intrinsic GTPase activity (Bishop and Hall, 2000).  Adaptor proteins 
Grb2 and SOS mediate RTK activation to Ras (Kao et al., 2001). This action occurs at the 
plasma membrane. Ras is targeted to the membrane due to lipid modifications of its 
cysteine-aliphatic-aliphatic-X (CAAX) motif (Wennerberg et al., 2005).  Ras activates 
cytoplasmic effectors MAPK kinase kinase, MAPK kinase, and MAPK to induce cellular 
proliferation, differentiation, and apoptosis dependent on the intensity and duration of the 
signal response (Rojas et al., 2012). In neuronal cells, it is the activation of MAPK that 
regulates the transcription of genes for neuronal development. 
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Figure 1.  MAPK and MK-STYX signaling cascade in PC12 cells. Neurotrophins such 
as NGF induce the homodimerization and trans-autophosphorylation of the receptor 
tyrosine kinase (RTK). This signal is mediated to the small-G-protein Ras. Ras cycles 
between an inactive-GDP bound form and an active GTP-bound form. Ras can activate 
the MAPK phosphorylation cascade. Sustained activation of MAPK, also known as 
ERK1/2, induces neuronal differentiation in PC12 cells. Mitogen activated phosphatases 
(MKPs) inactivate MAPKs. Due to shared structural homology with active MKPs, 
pseudophosphatase MK-STYX may directly affect activation of MAPK, indirectly affect 
the activity of MKPs, or play a role in a different signal transduction pathway.
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Mitogen Activated Protein Kinase 
 In mammalian cells, the activation of the different families of MAPKs initiates 
various cellular responses. The main families consist of the extracellular signal-regulated 
kinases (ERK), c-Jun N-terminal kinases (JNK), and p38 kinases (Roskoski, 2012). Each 
MAPK family is based on different threonine-Xxx-tyrosine motifs (Peng et al., 2010).  
Ras can activate the signal transduction pathway for all MAPK families. Though the p38 
and JNK family kinases primarily play a role in cellular stress responses, p38 and JNK 
activation has been found to play an important role in morphological changes associated 
with neuronal differentiation of PC12 cells (Kim et al., 2004; Sarina et al., 2013). 
However, it is well characterized that the sustained activation of ERK1/2 induces 
neuronal differentiation in PC12 cells. 
 Distinguishing it from the other MAPK families, ERK has a threonine-glutamic 
acid-tyrosine motif (Peng et al., 2010). ERK1 and ERK2 have 84% sequence identity 
sharing many, if not all, functions (Roskoski, 2012). ERK1/2 is activated by 
phosphorylation of threonine and tyrosine residues by dual specificity kinase, MAPK 
kinase (MEK) (Sweatt, 2001). Activation of ERK1/2 leads to the activation of 
transcription factors important for neuronal survival and plasticity (Sweatt, 2001; 
Cavanaugh et al., 2001). Temporal regulation of ERK1/2 is very important for the 
induction of neurite outgrowths. In PC12 cells, transient activation of ERK1/2 only 
induces cellular proliferation, whereas the sustained activation of ERK 1/2 leads to the 
induction of neuronal differentiation. This has been demonstrated through cellular 
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response to epidermal growth factor (EGF) and nerve growth factor (NGF) stimulus. 
NGF induces the sustained activation of ERK1/2 resulting in PC12 neuronal 
differentiation whereas EGF induces transient activation of ERK 1/2 resulting in PC12 
cellular proliferation (Nakafuku and Kaziro, 1993; Kao et al., 2001). Phosphatases 
catalyze the inactivation of ERK1/2 therefore regulating sustained or transient activation 
of ERK 1/2. Therefore, attention must be given to phosphatases as critical regulators of 
the rate and duration of signal responses. 
Protein Tyrosine Phosphatases in Neuronal Development
 Phosphatases are critical to regulating the phosphorylation cascades initiated by 
kinases. Unlike kinases which evolved from a common family, phosphatases evolved 
from structurally and mechanistically distinct families (Tonks, 2006). Protein tyrosine 
phosphatases (PTPs) are characterized by their catalytic signature motif: His-Cys-X5-Arg 
(HCX5R) (Pannider et al., 1998; Tonks, 2006).  PTPs can be divided between classical 
protein tyrosine phosphatases and dual-specificity phosphatases (Zhang, 2002; Anderson 
et al., 2004). The cysteine and arginine residues are critical for the PTP catalytic activity. 
PTPs catalyze protein dephosphorylation with a two step mechanism involving a 
nucleophilic attack of the phosphate by the sulfur atom of the cysteine residue, and 
function of the asparagine as a general acid for the protonating of the leaving group 
(Pannifer et al., 1998; Tonks, 2013).  Classical PTPs catalyze the removal of phospho-
tyrosine residues, whereas the dual-specificity phosphatases can accommodate both 
phospho-tyrosine and phospho-serine/phospho-tyrosine residues due to a broader active 
site (Tonks, 2006; Lim and Pawson, 2010). 
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PTPs can be positive or negative regulators of neuronal differentiation.  Studies have 
shown that the classical PTP, SHP-2, plays a positive role in the induction of PC12 
neuronal differentiation (Wright et al., 1997; Huang et al., 2012), whereas the classical 
PTP, SHP-1, negatively regulates the survival of neurons (Zhang, 2002). Similar to 
SHP-2, the dual-specificity phosphatase, PTEN, has been shown to promote neuronal 
differentiation (Lachyankar et al., 2000). Because prolonged activation of MAPK leads to 
neuronal differentiation of PC12 cells, this thesis focused research on the mitogen 
activated phosphatases (MKPs) family which dephosphorylate the MAPKs. 
Dual-specificity Mitogen Activated Phosphatases
  MKPs act antagonistically to the MAP kinases. Mammalian cells have 10 
catalytically active MKPs (Dickinson and Keyse, 2006; Caunt and Keyse, 2013). Dual-
specificity MKPs have a non-catalytic N-terminal cdc25 homology (CH2) domain and a 
C-terminal catalytic PTP domain (Tonks, 2006; Owens and Keyse, 2007). The CH2 
domain contains a kinase interaction motif (KIM) which mediates the specificity of 
interaction between the MKPs and the MAPK substrates (Caunt and Keyse, 2013; Tonks, 
2013). MKPs can recognize and inactivate a single class of MAP kinases or regulate 
more than one MAPK pathways (Owens and Keyse, 2007; Staples et al., 2010). MKP-1 
and MKP-2 are nuclear phosphatases that have substrate preferences for all three classes 
of MAPKs (Owens and Keyse, 2007). PC12 cell stimulation with EGF and NGF have 
been shown to induce an increase of MKP-1 and MKP-2 transcription (Misra-Press et al., 
1995). In constrast, in the case of MKP-3, a cytoplasmic phosphatase with a substrate 
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preference of ERK, transcription levels are increased only when stimulated with NGF in 
PC12 cells (Camps et al., 1998). MKP-3 expression is sustained for five days, suggesting 
its role in regulating sustained activation of MAPK induced by NGF stimulation (Camps 
et al., 1998). MKPs play an important role in the spatial-temporal regulation of MAPKs. 
However, phosphatases and kinases are not the sole regulators of phosphorylation 
cascades. Naturally occurring pseudo-enzymes are emerging as critical regulators of 
phosphorylation cascades. 
Pseudophosphatase MK-STYX
 Pseudo-enzymes are proteins that maintain the ability to bind the substrates of 
their active homologues but have amino acid substitutions rendering them catalytically 
inactive. Thus, they cannot catalyze the removal of phosphate groups. The prototype, 
pseudophosphatase STYX, named as an allusion for  the river of underworld, has a 
glycine substution for the nucleophilic cysteine rendering STYX catalytically inactive 
(Wishart et al., 1995). Sequence analysis of the STYX domain shows structural 
homology with the dual-specificity PTPs (Wishart and Dixon, 1998). 
Pseudophosphatases were thought to only function as “dominant-negative proteins” 
however our investigations strongly suggest that pseudophosphatase MK-STYX [MAPK 
(mitogen-activated protein kinase) phosphoserine/threonine/tyrosine-binding protein] is a 
critical regulator of signal transduction cascades. 
 MK-STYX is a pseudophosphatase member of the MKPs (Wishart et al., 1995; 
Hinton et al., 2010). MK-STYX is catalytically inactive due to phenylalanine and serine 
substitutions for critical active residues, histidine and nucleophilic cysteine, respectively 
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in the PTP signature motif (Tonks, 2006; Hinton et al., 2010). In the non-catalytic N-
terminal domain, MK-STYX has a cdc homology 25 (CH2) motif which is responsible 
for the specificity of MKP-MAPK interactions (Wishart and Dixon, 1998). MK-STYX is 
structurally homologous to active MKPs. Point mutations converting the phenyalalanine 
and serine residues to histidine and cysteine residues, respectively, generates a 
catalytically functional mutant of MK-STYX (Hinton et al., 2010).  As an inactive 
homolog to MKPs, we investigated the role of MY-STYX in neuronal differentiation of 
PC12 cells. 
Thesis Objectives
 Sustained activation of MAPK (ERK 1/2) induces neuronal differentiation in 
PC12 cells. MKPs regulate the duration of MAPK activation. Despite being catalytically 
inactive, MK-STYX shares structural homology with MKPs suggesting its role in 
neuronal differentiation of PC12 cells. This thesis investigated the role MK-STYX has in 
PC12 cell neuronal differentiation. The specific aims were as follows:
1) Does MK-STYX induce differentiation in PC12 cells? 
2) Does MK-STYX affect the small GTPases, Ras or Rho?
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METHODS 
Plasmids
 pMT2-FLAG-MK-STYX-FLAG was constructed as described in Hinton et al. 
(2010). The N-terminal and C-terminal ends of human MK-STYX were flanked by the 
FLAG epitope for MK-STYX detection. The integrity of the construct was confirmed by 
sequencing. 
Cell Culture
 All experiments used rat pheochromocytoma PC12 cells (ATCC). PC12 cells were 
grown at 37°C and 5% CO2 in Roswell Park Memorial Institute (RPMI) 1640 
(Invitrogen) supplemented with 10% horse serum (Invitrogen) and 5% fetal bovine serum 
(Invitrogen) or Dulbecco’s Modified Eagle Medium [DMEM] (Gibco) supplemented 
with 10% fetal bovine serum.  Cells were maintained with 15 ml per flask (Thermo 
Scientific) or 5 ml per 60 mm plate (Thermo Scientific). The medium of the cells was 
changed daily. 
Transfection
 Twenty-four hours post seeding, transient transfection of PC12 cells was 
performed using 2 µl Lipofectamine 2000 reagent per 2 µg DNA (Invitrogen). Cells were 
incubated with transfection reagents for five to six hours before the cell medium was 
removed and replaced with fresh medium.
MEK Inhibition Treatment
 PC12 cells were seeded at a confluency of  1.5!105 cells per well (Fischer). 
Twenty-four hours post transfection PC12 cells were treated with 50 µM of MEK 
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inhibitor, PD980509 (Cell Signaling). Two hours post inhibitor treatment, PC12 cells 
were stimulated with 100 ng/ml of NGF for three days. Live imaging of PC12 cells was 
conducted with differential interference contrast microscopy (DIC) and fluorescence 
microscopy using Nikon Eclipse Ti inverted fluorescence microscopy.
Time-dependent NGF Stimulation 
 Twenty-four hours post-transfection, PC12 cells were serum-starved in RPMI 
supplemented with 1% horse serum or DMEM with no serum supplementation for 
approximately 8 to 12 hours. PC12 cells were stimulated with 100 ng/ml of NGF 
(Prospec) for time points consisting of 0 minutes, 1 minute, 3 minutes, 5 minutes, 12 
minutes, 30 minutes, 24 hours, and 48 hours. PC12 cells were promptly lysed after nerve 
growth factor stimulation. 
Cell Lysis
  PC12 cells were lysed using lysis buffer (50 mM HEPES, pH 7.2, 150 mM NaCl, 
10% glycerol, 10 mM NaF, 1% Nonidet P-40 alternative [Calbiochem] and protease 
inhibitor cocktail tablets [Rochel]) or G-LISA lysis buffer (Cytoskeleton) and protease 
inhibitor cocktail (Cytoskeleton). On ice, cells were rinsed with 3 ml of cold 1!D-PBS. 
Cells were lysed and scrapped for approximately 1 minute. For the G-LISA assays, liquid 
nitrogen was used to snap-freeze the lysates for storage at 80°C. 
Immunoblotting 
 Lysates were sonicated and centrifuged at 14,000 rpm for 10 min. Protein 
concentration was determined using NanoDrop quantification. Lysates were diluted to 
obtain samples of 50 µg of protein with 6X Laemmli sample loading buffer and 
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dithiothreitol (DTT). Proteins were separated on a 10% SDS-PAGE for 45 minutes at 150 
volts. Protein gels were transferred to a PVDF membrane (GE Healthcare) using Trans-
Blot Semi-Dry Transfer Cell (BioRad). Proteins were immunoblotted with anti-STYXL1
(Sigma) or anti-FLAG (Sigma) to detect MK-STYX, anti-"-tubulin (Thermo Scientific) 
for loading control, and  in 5% milk 1X TTBS (Tween 20 Tris Saline Buffer). Protein 
bands were detected with enhanced chemiluminescence plus (GE Healthcare) and 
analyzed by autoradiography.
Fluorescence Microscopy 
 For live imaging, cells were plated at a confluency of 1.5!105 cells per well 
(Fischer). Live imaging of PC12 cells was conducted with differential interference 
contrast microscopy (DIC) and fluorescence microscopy using Nikon Eclipse Ti inverted 
fluorescence microscopy.
Ras G-LISA
 The protocol of the Cytoskeleton Ras G-LISA Activation Assay Biochem Kit was 
followed using the reagents provided.
 Protein concentration was determined using NanoDrop quantification of a 6 µl 
aliquot of sample prior to snap-freezing. Lysates were thawed in a room temperature 
water bath then clarified by centrifugation for 1 minute at 4°C and 10,000 rpm. Control 
protein, blanks, and equalized sample protein concentrations of 0.4 mg/ml to 2.0 mg/ml 
were added to appropriate wells of the G-LISA plate. The G-LISA plate was incubated on 
a rotator at 4°C for 30 minutes. The G-LISA plate was washed three times with wash 
buffer. The G-LISA plate was incubated for 2 minutes with antigen presenting buffer. The 
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plate was washed three times with wash buffer. The G-LISA plate was then incubated 
with an anti-Ras primary solution of 1:50 dilution in antibody dilution buffer for 45 
minutes at room temperature on a rocker. The primary solution was removed and the G-
LISA plate was washed three times with wash buffer. Subsequently, the G-LISA plate 
was incubated with a horseradish peroxidase secondary solution of 1:250 dilution in 
antibody dilution buffer for 45 minutes at room temperature on a rocker. The secondary 
solution was removed and the G-LISA plate was washed three times with wash buffer. 
The G-LISA plate was then incubated at room temperature with 50 #l of mixed 
horseradish peroxidase (HRP) detection reagent for 15 minutes. After 15 minutes, 50 #l 
of HRP Stop Buffer was added to each well. The signal was detected by measuring 
absorbance at 490 nm using a microplate spectrophotometer.
RhoA G-LISA
 The protocol of the Cytoskeleton Inc. RhoA G-LISA Activation Assay Biochem 
Kit was followed using the reagents provided.
 Protein concentration was determined using NanoDrop quantification of a 6 µl 
aliquot of sample prior to snap-freezing. Lysates were thawed in a room temperature 
water bath then clarified by centrifugation for 1 minute at 4°C and 10,000 rpm. Control 
protein, blanks, and equalized sample protein concentrations of 0.4 mg/ml to 2.0 mg/ml 
were added to appropriate wells of the G-LISA plate. The G-LISA plate was incubated on 
a rotator at 4°C for 30 minutes. The G-LISA plate was washed three times with wash 
buffer. The plate was incubated for 2 minutes with antigen presenting buffer. The G-
LISA plate was washed three times with wash buffer. The G-LISA plate was then 
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incubated with an anti-RhoA primary solution of 1:250 dilution in antibody dilution 
buffer for 45 minutes at room temperature on a rocker. The primary solution was 
removed and the plate was washed three times with wash buffer. Subsequently, the plate 
was incubated with a horseradish peroxidase secondary solution of 1:62.5 dilution in 
antibody dilution buffer for 45 minutes at room temperature on a rocker. The secondary 
solution was removed and the plate was washed three times with wash buffer. The plate 
was then incubated at 37°C with 50 #l of mixed horseradish peroxidase (HRP) detection 
reagent for 15 minutes. After 15 minutes, 50 #l of HRP Stop Buffer was added to each 
well. The signal was detected by measuring absorbance at 490 nm using a microplate 
spectrophotometer.
RhoA ELISA
 The protocol of the Cytoskeleton Inc. Total RhoA ELISA Kit was followed using 
the reagents provided and the lysates used in the RhoA G-LISA assay. 
 RhoA wild-type His-tag positive controls and samples were prepared at a ratio of 
1:4 with sample dilution buffer. Diluted RhoA positive controls and samples were added 
to each well. The ELISA plate was incubated for 2 hours undisturbed at room 
temperature. After 2 hours, the ELISA plate was washed three times with wash buffer. 
The ELISA plate was then incubated with antigen presenting buffer at room temperature, 
undisturbed for 2 minutes. After 2 minutes, the ELISA plate was washed three times with 
wash buffer. The ELISA plate was next incubated with an anti-RhoA primary solution 
dilution of 1:2000 in wash buffer for 1 hour at room temperature, undisturbed. After 1 
hour, the ELISA plate was washed three times with wash buffer. Subsequently, the 
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ELISA plate was incubated with a horseradish peroxidase secondary solution dilution 
1:300 in wash buffer for 1 hour at room temperature, undisturbed. After 1 hour the 
ELISA plate was washed five times with wash buffer. The ELISA plate was incubated at 
room temperature with Horseradish peroxidase detection reagent for 15 minutes. After 15 
minutes, a stop solution of 1.8 M sulfuric acid was added to each well. The signal was 
detected by measuring absorbance at 490 nm using a microplate spectrophotometer.
RESULTS  
MK-STYX is endogenously expressed in PC12 cells
 It is well characterized that sustained activation of MAPK, also known as 
ERK1/2, induces neuronal differentiation of PC12 cells. ERK1/2 is activated by serine/
threonine and tyrosine residue phosphorylation. MKPs such as MKP1 inactivate ERK1/2 
by hydrolysis of the phosphorylated residues. MK-STYX is structurally homologous to 
the MKPs that regulate the duration of ERK1/2 activation. This suggests that MK-STYX 
may play a role in neuronal differentiation by sustaining activation of ERK1/2. Therefore, 
to begin the investigation of MK-STYX in PC12 cells, the presence of endogenous MK-
STYX was first confirmed.
 Previous studies have detected MK-STYX in human embryonic kidney (HEK) 
cells (Hinton et al., 2010). This finding was confirmed as a control. PC12 and HEK 
lysates transfected with MK-STYX and non-transfected PC12 and HEK lysates were 
immunblotted with anti-STYXL1 antibody. Over-expression of MK-STYX was also 
detected by anti-FLAG, the tag to MK-STYX within the pMT2 vector (Hinton et. al, 
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2010). The presence of endogenous MK-STYX suggests that MK-STYX would be 
available to serve as a regulator of signal transduction cascades in PC12 cells (Figure 2). 
Figure 2.  MK-STYX is endogenously expressed in PC12 cells. PC12 and HEK cells 
were transiently transfected with a pMT2-FLAG-MK-STYX-FLAG. Transfected and 
non-transfected whole cell lysates were lysed and resolved on a 10% SDS-PAGE gel. 
Immunoblot analysis was performed with anti-STYXL1. (A) Immunoblot analysis 
confirmed the presence of endogenous and over-expressed MK-STYX in PC12 and HEK 
cells. (B) To confirm that FLAG-tagged MK-STYX was over-expressed, immunoblot 
analysis was performed with anti-FLAG. 
MK-STYX induces neuronal differentiation
The expression of endogenous MK-STYX in PC12 cells suggests it could play a role as a 
regulator of signal transduction cascades. In order to investigate the effect MK-STYX has 
on the morphological changes of PC12 cells, MK-STYX was over-expressed. PC12 cells 
were transfected with pEGFP and pMT2 or pEGFP and pMT2-FLAG-MK-STYX. PC12 
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cells were scored for the presence of neurite extensions, defined as protrusions greater 
than 20 µm in length. For each experiment 100 cells were scored (Figure 3).
Within 5 days, over-expression of MK-STYX alone was found to induce more cells to 
have neurite outgrowths. This strongly suggests that MK-STYX induces neuronal 
differentiation of PC12 cells.
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Figure 3. MK-STYX induces neuronal differentiation of PC12 cells. Representative 
examples are presented to illustrate the growth of neurites in PC12 cells 5 days after 
transfection (A). Cells were scored for neurite extensions greater than 20µm in length 
(B). Cells transfected with pMT2-FLAG-MK-STYX-FLAG showed significant induction 
of neurite outgrowth. This work was performed in collaboration with Kristen Wong. 
Three replicates of this experiment were performed.
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MK-STYX promotes neurite extensions in the absence and presence of NGF
 Based on the previous observation that MK-STYX alone was inducing more cells 
to have neurite outgrowth, we wanted to observe the effects of MK-STYX in nerve 
growth factor (NGF) stimulated PC12 cells. It is well known that NGF induces the 
differentiation and neuronal outgrowth of PC12 cells. Previous studies have shown that 
NGF dose dependently induces neurite outgrowth (Waetzing and Herdegen, 2003).  
Compared to cells treated with lower concentrations, 50 or 100 ng/ml NGF stimulation of 
PC12 cells resulted in more cells with neurite outgrowths (Waetzing and Herdegen, 
2003).  
 PC12 cells were treated with 100 ng/ml of NGF to determine if MK-STYX 
enhanced the effect of NGF stimulation. We found that PC12 cells expressing MK-STYX 
had longer neurite extensions. These findings suggest that MK-STYX sustains MAPK 
activity. (Figure 4)
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 Figure 4. MK-STYX produces neurite extensions in the absence (A) and presence of 
NGF (B). PC12 cells were plated at a concentration of 1.5 x 105 cells. PC12 cells were 
transfected with pEGFP and pMT2 or pMT2-FLAG -MK-STYX and pEGFP. 24 hours 
post-transfection, PC12 cells were stimulated with 100 ng/ml of NGF. 48 hours post-
transfection, live PC12 cells were imaged using DIC and fluorescence microscopy. NGF 
induced all of the PC12 cells to differentiate: however, PC12 cells expressing MK-STYX 
were found to have longer neurite extensions. Three replicates of this experiment was 
performed.
 MK-STYX does not stimulate Ras activation
 We have found that MK-STYX induces neuronal outgrowth in PC12 cells, as well 
as promotes the extension of neuronal outgrowths in the presence of NGF. This leads to 
the question of the molecular mechanism by which MK-STYX plays a role in PC12 
neuronal differentiation and outgrowth. 
 The Ras-MAPK cascade is a critical component of neuronal differentiation. It is 
well characterized that NGF binding to TrkA activates a Ras-dependent mitogen activated 
protein kinase (MAPK) cascade (Nusser et al., 2002). Through this cascade, sustained 
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activation of ERK1/2 results in the arrest of the growth cycle and stimulation of the 
differentiation of PC12 cells (Jeon et al., 2012). To begin investigations of the mechanism 
of action, we studied the activation patterns of the initiator of the MAPK cascade, 
GTPase Ras. Within minutes of RTK stimulation, Ras is activated leading to the 
induction of the MAPK pathway (Schiller, 2006). PC12 cells were time-dependently 
stimulated with NGF to characterize whether MK-STYX induced activation of Ras.  
PC12 cells were lysed and Ras activation was analyzed using a Ras G-LISA Activation 
Assay Biochem Kit. Statistical t-test analysis found that MK-STYX caused a significant 
decrease in Ras activation within 1 minute (Figure 5 and Table 1). However, this decrease 
was transient and Ras returned to active control levels within 3 minutes. GTPase Ras 
activates multiple signal transduction pathways. This decrease in Ras inactivation may 
not affect the activation of the MAPK pathway; however, which lead us to investigation 
further downstream of the MAPK pathway.
25
Figure 5. MK-STYX does not stimulate prolonged Ras activation. PC12 cells were 
transfected with pMT2 or pMT2-FLAG-MK-STYX. 24 hours post-transfection, PC12 
cells were serum-starved for approximately 12 hours to bring Ras activity to basal levels. 
PC12 cells were stimulated with 100 ng/ml of NGF for 1, 3, 5, and 30 minutes.  PC12 
cells were lysed and activation of Ras was quantified with a Ras GLISA. Three replicates 
of this experiment were performed. Error bars indicate +/- Standard Error Mean (SEM). 
* = p = 0.013 (see Table 1)
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*
Time point T-test Significance
0 minutes 0.859 Not Significant
1 minute 0.013 Significant 
3 minutes 0.127 Not Significant
5 minutes 0.498 Not Significant
30 minutes 0.537 Not Significant
Table 1. MK-STYX causes a transient decrease of Ras activation. Statistical two-
tailed, equal variant t-test analysis was conducted comparing activation of PC12 cells 
transfected with pMT2 or MK-STYX at each time point. Statistical analysis showed that 
MK-STYX induced a transient significant decrease in Ras activation. GTPase Ras is an 
activator of multiple signal transduction cascades so this inactivation may not affect the 
activity of the MAPK cascade. 
MK-STYX induces neurite growth independent of the MAPK pathway 
To determine whether MK-STYX functions through modification of the MAPK pathway, 
we inhibited the activity of dual-specificity kinase, MEK. MEK induces activation of 
ERK1/2 through phosphorylation. Sustained activation of ERK1/2 mediates the initiation 
of neurite outgrowths in PC12 cells. Therefore, inhibition of MEK kinase should inhibit 
the induction of neurite growths of PC12 cells. The MEK inhibitor prevented neurite 
outgrowth in PC12 control empty pMT2 vector expressing control cell.  However, cells 
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transfected with MK-STYX maintained expression of neurite outgrowths. This strongly 
suggests that MK-STYX functions independently of the MAPK cascade (Figure 6). 
Figure 6. MK-STYX causes neurite outgrowth despite addition of a MEK inhibitor. 
PC12 cells were transfected with pMT2-FLAG-MK-STYX. 24hr post-transfection, cells 
were treated with PD980509 for 2 hr prior to NGF stimulation. Cells were treated with 
100 ng/ml NGF and scored for neurites 72 hr after stimulation. Three replicates of this 
experiment were performed.  Error bars indicate +/- Standard Error Mean. This work was 
performed in collaboration with Kristen Wong.
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MK-STYX decreases activation of RhoA 
 MK-STYX was found to function independently of the MAPK cascade shifting 
our focus to other pathways involved in neuronal differentiation. PC12 cells grow and 
proliferate in a relatively round shape. This round morphology must be changed for 
formation of neurite outgrowths, and involves reorganization of the actin cytoskeleton 
(Govek et al., 2005). The Rho GTPases are involved in actin cytoskeleton remodeling. 
Studies utilizing dominant-negative RhoA, shRNA-mediated RNA interference, and Rho-
ADP-ribosyltransferase C3 toxin (Clostridium botulinum C3 Rho-ADP-ribosylating 
exoenzyme), which specifically inactivates Rho isoforms, RhoA, RhoB, and RhoC, have 
verified that RhoA inactivation is necessary for the induction of neurite outgrowths in 
PC12 cells (Sebök et al, 1991; Bishop and Hall, 2000; Fan et al., 2008). Similar to the 
activation of Ras, RhoA responds to receptor tyrosine kinase activation (Schiller, 2006). 
We conducted time-dependent NGF stimulation trials to determine if MK-STYX induced 
a decrease of RhoA activation.
 Activation of RhoA was quantified with a RhoA GLISA. RhoA GLISA data were 
normalized for total RhoA using a RhoA ELISA.  PC12 cells expressing MK-STYX had 
lower levels of RhoA activation. This correlates with studies showing that over-
expression of MK-STYX induces neuronal differentiation of PC12 cells (Figure 7).
29
  
0
12.5
25.0
37.5
50.0
0 min. 1 min. 3 min. 5 min. 12 min. 30 min. 24 hr. 48 hr. 
Pe
rc
en
ta
ge
 o
f A
ct
iv
e 
R
ho
A
Time points
    pMT2 Average MK Average 
Figure 7.  MK-STYX decreases RhoA activation. Inactivation of RhoA is required for 
the induction of neurite outgrowths in PC12 cells. PC12 cells were transfected with 
pMT2 or MK-STYX. 24 hours post-transfection, PC12 cells were stimulated with 100 
ng/ml NGF at various time points. PC12 cells were lysed, and activation of RhoA was 
quantified with a RhoA G-LISA. Total RhoA was normalized with a RhoA ELISA.  Three 
replicates of this experiment was performed.  Error bars indicate +/- Standard Error 
Mean. 
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DISCUSSION 
PC12 cell differentiation
The PC12 cell line is a model system for the study of neuronal differentiation. The 
neurotrophin NGF signals through the Trk receptor inducing sustained activation of 
ERK1/2.  It is well characterized that sustained activation of ERK1/2 causes a cessation 
of PC12 cellular proliferation and induces neuronal outgrowths. We have shown that 
MK-STYX plays a critical role in the induction of PC12 neuronal differentiation. We 
have confirmed that MK-STYX is endogenously expressed in PC12 cells and over-
expression of MK-STYX alone can induce neuronal outgrowths of PC12 cells.  
Furthermore we have found that MK-STYX enhances the effect of NGF by promoting 
longer neurite outgrowths in PC12 cells stimulated with NGF. This study strongly 
suggests that MK-STYX plays a role in signal transduction pathways involved in 
neuronal differentiation and neuronal outgrowth of PC12 cells. MK-STYX is structurally 
homologous to MKPs. Like MKPs, MK-STYX has a N-terminal CH2 domain for 
protein-protein interaction and a C-terminal dual-specificity phosphatase domain 
(Wishart and Dixon, 1998). The structural homology of MKPs and MK-STYX suggests 
that these proteins share similar substrates and may directly interact with each other. 
Therefore, we began our investigations with the modulation of the MAPK cascade.  
 NGF factor stimulation activates a Ras-dependent MAPK cascade leading to 
sustained activation of ERK1/2 (Nusser et al., 2002). We investigated the activation 
pattens of the initiator of the MAPK cascade, GTPase Ras. Ras cycles between an active 
GTP-bound form and inactive GDP-bound form. The action of GEFs and GAPs regulate 
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Ras activation. Studies have shown, despite NGF stimulation, that dominant-negative Ras 
blocks neuronal differentiation of PC12 cells; therefore, GTPase Ras is critical for 
initiating the sustained Ras-dependent MAPK signal transduction cascade for PC12 
neuronal differentiation (Nakafuku and Kaziro, 1993). Our time-dependent NGF 
stimulation studies of PC12 cells found a transient decrease in Ras activation at 1 minute 
for PC12 cells over-expressing MK-STYX. Ras activation returned to control activation 
levels within 3 minutes. This finding may seem contradictory of earlier observations that 
MK-STYX induced neuronal differentiation of PC12 cells. However, Ras is involved in 
the activation of various signaling pathways involved in cellular proliferation, stress 
responses, apoptosis, and other cellular responses (Owens and Keyse, 2007). 
Furthermore, the mammalian subfamily of Ras proteins has various isoforms. These 
isoforms have a high degree of sequence identity, common downstream effectors, 
upstream activators, and overlapping functions (Castellano and Santos, 2011). The Ras 
G-LISA activation assay does not differentiate between the different isoforms of the Ras 
subfamily.  The decrease of Ras activation may have been a Ras isoform not involved in 
neuronal differentiation. This leads to investigations further downstream MAPK cascade 
effectors.
MEK is a dual specificity kinase of ERK1/2 (Sweatt, 2001). Inhibition of MEK 
with PD980589 should cease activation of ERK1/2 (Crews et al. 1992). PC12 cells 
transfected with the empty pMT2 vector had a significant reduction of PC12 cells 
expressing neurite outgrowths in the presence of the MEK inhibitor despite stimulation 
with NGF. However, PC12 cells expressing MK-STYX maintained expression of neurite 
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outgrowths similar to the control. This strongly suggests that MK-STYX functions 
independently of the MAPK cascade. Previous studies of MK-STYX siRNAs in HeLa 
cells found that RNA-silencing of MK-STYX did not have a significant effect on the 
activation of ERK 1/2 (Niemi et al., 2011). This suggests that MK-STYX does not 
directly sustain activation of phospho-ERK1/2. Further studies of phospho-ERK1/2 
immunoblotting of PC12 cells with MEK inhibition will verify if MK-STYX induces 
activation of ERK1/2 independent of the MAPK cascade. Furthermore, co-
immunoprecipitation analysis can be performed to establish whether ERK1/2 and MK-
STYX interact directly, though we hypothesize these proteins do not due to previous 
studies in HeLa cells (Niemi et al., 2011).
 Due to the structural homology with MKPs, MK-STYX may play a role in the 
modulation of other MAPKs such as JNK and p38 kinases. JNK and p38 kinases are 
associated with roles in regulation of cellular stress and apoptosis. However, activation of 
JNK and p38 kinases are critical for neuronal differentiation of PC12 cells (Waetzing and 
Herdegen, 2003; Sarina et al., 2013). Waetzing and Herdegen suggest that ERK1/2 and 
JNK synergistically activate NGF-stimulated PC12 cell neuronal differentiation and 
neurite outgrowth (2003). Their studies suggest that JNKs are responsible for neurite 
formation, whereas ERK 1/2 is responsible for neurotransmission (Waetzing and 
Herdegen, 2003). MK-STYX has structural homology with MKP-1 and MKP-2, both of 
which bind all classes of MAPK (Wishart and Dixon, 1998). Therefore, MK-STYX may 
play a role in the activation of other MAPKs or effect the activity of the associated 
MKPs. 
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Inactivation of RhoA
 Within the Ras GTPase superfamily is the Rho subfamily consisting of Rac, Rho, 
and Cdc25.  These highly conserved, eukaryotic GTPases dynamically regulate the actin 
cytoskeleton morphology. Rho GTPases cycle between an inactive GDP bound form and 
an active GTP bound form. These conversions are tightly regulated by GEFs and GAPs. 
Rho GTPases have an additional level of regulation with Rho guanine nucleotide 
dissociation inhibitors (RhoGDIs), which inhibit the spontaneous exchange of GDP to 
GTP by isolating GDP-bound Rho in the cytoplasm (Bishop and Hall, 2000). 
 It is well characterized that RhoA inactivation is required for the induction of 
neuronal outgrowths in PC12 cells. Studies utilizing dominant-negative RhoA, shRNA-
mediated RNA interference, and C3 toxin have verified that RhoA inactivation is 
necessary for the induction of neurite outgrowths in PC12 cells (Sebök et al, 1991; 
Bishop and Hall, 2000; Fan et al., 2008). Furthermore, Sebök et al. produced a simple 
model to verify the different roles of RhoA in PC12 neuronal differentiation. Sebök et al., 
established that the rate of neurite extension of postmitotic, neuronally differentiated 
PC12 cells was accelerated by activated RhoA expression, but decelerated by dominant 
negative RhoA expression (1991).
 Our studies found that MK-STYX inactivated RhoA. PC12 cells expressing MK-
STYX maintained low levels of RhoA activation compared to control activation levels. 
Activation of RhoA increased within 48 hours of NGF-stimulation of PC12 cells. This 
correlates with our live imaging findings that MK-STYX promotes NGF-induced 
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neuronal outgrowth in PC12 cells. Within 48 hours, PC12 cells seems to shift from 
inducing neurite outgrowth to extending neurite outgrowth length. RhoA has different 
roles for the different stages of PC12 neuronal differentiation and outgrowth. RhoA 
inactivation is required for the induction of neurite outgrowths, whereas activation of 
RhoA promotes neurite outgrowth extension (Sebök et al., 1991). MK-STYX seems to 
follow this pattern of activation. We found that MK-STYX alone can induce neuronal 
differentiation of PC12 cells, explaining the low RhoA activation levels prior to NGF 
stimulation. We have also visualized PC12 cells with longer neurite outgrowths at 48 
hours post-NGF stimulation explaining the increase in RhoA activation. Future 
investigations of downstream effectors of RhoA such as Rho-associated protein kinase 
(ROCK) are required to further verify inactivation of RhoA. GTP-bound RhoA disrupts 
the intramolecular autoinhibitory interactions within ROCK to expose the functional 
domains (Bishop and Hall, 2000; Nusser et al., 2002).  
 The role of MK-STYX in the mechanism of RhoA inactivation remains to be 
determined. Other studies have suggested mechanisms of RhoA inactivation in PC12 
neuronal differentiation. Nusser et al. demonstrated that NGF induces protein kinase A 
(PKA) to mediate phosphorylation of RhoA on serine188  in the C-terminal tail rendering 
RhoA unable to bind to ROCK (2006). The RhoA and MAPK pathways are not 
independent signal transduction cascades. These pathways have important mechanisms of 
crosstalk. 
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Crosstalk between MAPK and RhoA
Similar to the activation of the Ras-MAPK pathway by RTKs, RhoA GTPases are 
activated within minutes of RTK stimulation due to Rho GEF mediation (Schiller, 2006).  
Previous studies have demonstrated that 16 of the 69 known human Rho GEFs are 
involved in the connection of RTK simulation and Rho GTPase activation (Schiller, 
2006). The Rho GEFs may take advantage of Rho GTPase recruitment to the membrane. 
Rho GTPases have a CAAX (Cysteine-aliphatic-aliphatic-Xxx) motif in the C-terminus 
that mediates their localization to the membrane (Schiller, 2006). Rho GEF can directly 
interact with the RTK allowing the quick activation of the Rho GTPase due to their 
proximity at the membrane (Schiller, 2006). MK-STYX may be involved in inhibition of 
Rho GEF activity or stimulation of Rho GAP activity. 
Summary and Future Directions
 This study has initiated investigations of the role of MK-STYX in neuronal 
differentiation. This thesis provides evidence that over-expression of MK-STYX alone 
can cause neuronal differentiation, MK-STYX induces neuronal differentiation 
independent of the MAPK cascade, and MK-STYX causes inactivation of RhoA. These 
studies implicate a potential therapeutic use of MK-STYX. The disruption of the 
coordination of protein phosphorylation and dephosphorylation leads to the 
neurological diseases such as Alzheimer’s disease. Proteins such as Tau have been shown 
to be hyperphosphorylated in patients diagnosed with Alzheimer’s disease (Hu et al., 
2002). Gaining insight on the role of MK-STYX in neuronal differentiation can lead to 
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future development of MK-STYX as a therapeutic for the treatment of neurological 
disorders and injuries.  
 Further studies of MK-STYX in PC12 neuronal differentiation will focus on 
understanding the mechanism of action of MK-STYX.  Phospho-ERK1/2 
immunoblotting of PC12 cells with MEK inhibition will be conducted to verify whether 
MK-STYX induces activation of ERK1/2 independent of the MAPK cascade. 
Immunoblotting for ROCK will be done to verify inactivation of RhoA. Co-
immunopreciptation analysis will be performed to establish whether MK-STYX interacts 
directly with MAPKS and MKPs. Finally, MK-STYX knockdown studies will be 
conducted to determine whether MK-STYX is necessary for PC12 neuronal 
differentiation. This work was funded by a NSF grant (MCB 1113617 to SDH). 
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